Volume | 6,072,646 |
|
|||||
News | - | ||||||
Day High | 7.61 | Low High |
|||||
Day Low | 5.85 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Ocular Therapeutix Inc | OCUL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
7.60 | 5.85 | 7.61 | 5.86 | 7.58 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
42,358 | 6,072,646 | $ 6.50 | $ 39,491,664 | - | 1.995 - 11.31 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:05:29 | formt | 242 | $ 5.98 | USD |
Ocular Therapeutix (OCUL) Options Flow Summary
Ocular Therapeutix Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
869.47M | 148.63M | - | 58.44M | -80.74M | -0.54 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ocular Therapeutix News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCUL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.02 | 8.345 | 5.86 | 7.89 | 1,213,282 | -2.04 | -25.44% |
1 Month | 9.98 | 10.28 | 5.86 | 8.57 | 1,396,536 | -4.00 | -40.08% |
3 Months | 4.13 | 11.31 | 4.11 | 8.58 | 2,149,971 | 1.85 | 44.79% |
6 Months | 2.58 | 11.31 | 1.995 | 6.50 | 1,696,336 | 3.40 | 131.78% |
1 Year | 5.83 | 11.31 | 1.995 | 5.98 | 1,346,947 | 0.15 | 2.57% |
3 Years | 16.08 | 19.84 | 1.995 | 6.76 | 1,050,440 | -10.10 | -62.81% |
5 Years | 3.64 | 24.30 | 1.995 | 7.73 | 985,183 | 2.34 | 64.29% |
Ocular Therapeutix Description
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. |